Obio Technology (Shanghai) Corp., Ltd. (688238.SS)
- Previous Close
5.52 - Open
5.48 - Bid 5.46 x --
- Ask 5.47 x --
- Day's Range
5.40 - 5.53 - 52 Week Range
4.78 - 13.62 - Volume
4,860,521 - Avg. Volume
9,559,274 - Market Cap (intraday)
3.535B - Beta (5Y Monthly) 0.48
- PE Ratio (TTM)
-- - EPS (TTM)
-0.22 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
8.20
Obio Technology (Shanghai) Corp., Ltd., a biotechnology company, focuses on the development of gene therapy vectors in China. The company provides gene function and gene therapy research, and other CRO services, such as drug target and drug efficacy research. It also offers CDMO services, such as process development and testing, IND-CMC pharmaceutical research, and clinical sample GMP production for the research and development of genetic drugs. The company was founded in 2013 and is headquartered in Shanghai, China.
www.obiosh.comRecent News: 688238.SS
Performance Overview: 688238.SS
Trailing total returns as of 5/30/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 688238.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 688238.SS
Valuation Measures
Market Cap
3.57B
Enterprise Value
3.25B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
15.19
Price/Book (mrq)
1.77
Enterprise Value/Revenue
13.90
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-59.24%
Return on Assets (ttm)
-4.57%
Return on Equity (ttm)
-6.65%
Revenue (ttm)
233.59M
Net Income Avi to Common (ttm)
-138.37M
Diluted EPS (ttm)
-0.22
Balance Sheet and Cash Flow
Total Cash (mrq)
577M
Total Debt/Equity (mrq)
12.40%
Levered Free Cash Flow (ttm)
-339.32M
Research Analysis: 688238.SS
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: 688238.SS
688238.SS does not have Company Insights